Literature DB >> 17115069

Alpha(2A)-adrenoceptors regulate sympathetic transmitter release in mice kidneys.

O Vonend1, S Habbel, J Stegbauer, J Roth, L Hein, L C Rump.   

Abstract

BACKGROUND AND
PURPOSE: In the present study, a rodent model was used to investigate whether the alpha(2A)-adrenoceptor (alpha(2A)) represents the presynaptic autoinhibitory receptor regulating sympathetic transmitter release in the kidney. Moreover, the potential role of alpha(2A) as a heteroceptor regulating adenosine triphosphate (ATP) release was tested. EXPERIMENTAL APPROACH: Kidneys from wild-type (WT) and alpha(2A)-knockout (KO) mice were isolated and perfused. Renal nerves were stimulated with platinum-electrodes. Endogenously released noradrenaline (NA) was measured by HPLC. The perfusion pressure was monitored continuously. KEY
RESULTS: Renal nerve stimulation (RNS) induced a frequency (1,2,5,7.5,10,15 Hz)-dependent release of NA in WT mice (994+/-373, 2355+/-541, 6375+/-950, 11626+/-1818, 19138+/-2001 pg NA g(-1) kidney (means+/-s.e.m.)). There was a 2.7-fold (5 Hz) increase of NA release in alpha(2A)-KO mice. In WT animals alpha-adrenoceptor blockade by phentolamine increased RNS-induced NA release in a concentration-dependent manner up to 350% of control. No facilitation by phentolamine was observed in alpha(2A)-KO mice. Pressor responses to 1 Hz and 2 Hz were resistant to alpha(1)-adrenoceptor blockade (0.03 microM prazosin) but abolished by P(2) receptor blockade (5 microM PPADS). Blockade of alpha(2)-adrenoceptors (1 microM rauwolscine) increased these purinergic pressor responses to 296+/-112% (1 Hz) in WT but not in alpha(2A)-KO mice. Exogenous ATP (100 microM) increased basal but not RNS-induced NA release. CONCLUSIONS AND IMPLICATIONS: alpha(2A)-Adrenoceptor-activation inhibits NA and ATP release from renal sympathetic nerves. Pressor responses to RNS at higher stimulation frequencies (>2 Hz) are mediated by NA. At lower frequencies neuronally released ATP seems to be the predominant transmitter mediating renovascular resistance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17115069      PMCID: PMC2013843          DOI: 10.1038/sj.bjp.0706961

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

Review 1.  Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications.

Authors:  G Lambrecht
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-11       Impact factor: 3.000

Review 2.  Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia?

Authors:  L C Rump; K Amann; S Orth; E Ritz
Journal:  Nephrol Dial Transplant       Date:  2000-11       Impact factor: 5.992

Review 3.  Renal microvascular effects of P2 receptor stimulation.

Authors:  E W Inscho
Journal:  Clin Exp Pharmacol Physiol       Date:  2001-04       Impact factor: 2.557

4.  P2-receptor modulation of noradrenergic neurotransmission in rat kidney.

Authors:  C Bohmann; I von Kügelgen; L C Rump
Journal:  Br J Pharmacol       Date:  1997-08       Impact factor: 8.739

Review 5.  P2-receptors controlling neurotransmitter release from postganglionic sympathetic neurones.

Authors:  I von Kügelgen; W Nörenberg; H Koch; A Meyer; P Illes; K Starke
Journal:  Prog Brain Res       Date:  1999       Impact factor: 2.453

6.  Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification.

Authors:  W Lorenz; J W Lomasney; S Collins; J W Regan; M G Caron; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1990-11       Impact factor: 4.436

Review 7.  Neurogenic factors and hypertension in chronic renal failure.

Authors:  V M Campese
Journal:  J Nephrol       Date:  1997 Jul-Aug       Impact factor: 3.902

8.  Renal periarterial nerve stimulation-induced vasoconstriction at low frequencies is primarily due to release of a purinergic transmitter in the rat.

Authors:  D D Schwartz; K U Malik
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

9.  Contraction-mediating alpha 2-adrenoceptors in the mouse vas deferens.

Authors:  R Bültmann; I von Kügelgen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

10.  Norepinephrine-related mechanism in hypertension accompanying renal failure.

Authors:  D Schohn; P Weidmann; H Jahn; C Beretta-Piccoli
Journal:  Kidney Int       Date:  1985-11       Impact factor: 10.612

View more
  3 in total

1.  Regulation of renal sympathetic neurotransmission by renal α(2A)-adrenoceptors is impaired in chronic renal failure.

Authors:  Henning Hoch; Johannes Stegbauer; Sebastian A Potthoff; Lutz Hein; Ivo Quack; Lars Christian Rump; Oliver Vonend
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

2.  α2A-Adrenoceptors Modulate Renal Sympathetic Neurotransmission and Protect against Hypertensive Kidney Disease.

Authors:  Lydia Hering; Masudur Rahman; Henning Hoch; Lajos Markó; Guang Yang; Annika Reil; Mina Yakoub; Vikram Gupta; Sebastian A Potthoff; Oliver Vonend; Donna L Ralph; Susan B Gurley; Alicia A McDonough; Lars C Rump; Johannes Stegbauer
Journal:  J Am Soc Nephrol       Date:  2020-02-21       Impact factor: 10.121

3.  Renal denervation prevents long-term sequelae of ischemic renal injury.

Authors:  Jinu Kim; Babu J Padanilam
Journal:  Kidney Int       Date:  2014-09-10       Impact factor: 10.612

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.